Argenx (ARGX.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Quote List Quote List

Event Tracking

Dec17

RBC Capital Analyst Maintains Argenx Buy Rating

11:52

Dec16

Jefferies Analyst Maintains Buy Rating for Argenx Se with Price Target at $950

15:27

Dec15

arGEN-X SE Halts Phase III Clinical Trial of Efgartigimod for Thyroid Eye Disease

06:00

Dec5

Morgan Stanley Raises Argenx Price Target to $1,110

15:41

Nov18

Argenx SE's Compensation Policy Approved by Extraordinary General Meeting

22:36

Argenx Shares Reach New 52-Week High, Citi Raises Price Target

06:49

Schedules & Filings

Schedules

Filings

Oct30

Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 1.151 B, Net Income 344.26 M, EPS 5.18

Jul31

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 967.19 M, Net Income 245.36 M, EPS 3.7403

May8

Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 807.37 M, Net Income 169.47 M, EPS 2.58

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change